A detailed history of Credit Agricole S A transactions in Pfizer Inc stock. As of the latest transaction made, Credit Agricole S A holds 2,360,366 shares of PFE stock, worth $64.8 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
2,360,366
Previous 250,000 844.15%
Holding current value
$64.8 Million
Previous $6.94 Million 852.04%
% of portfolio
0.36%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $40.7 Million - $47.7 Million
1,611,318 Added 215.12%
2,360,366 $66 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $14.8 Million - $16.9 Million
-569,971 Reduced 43.21%
749,048 $20.8 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $11.6 Million - $15.1 Million
444,949 Added 50.91%
1,319,019 $38 Million
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $2.04 Million - $2.38 Million
-63,487 Reduced 6.77%
874,070 $29 Million
Q2 2023

Jul 31, 2023

BUY
$36.12 - $41.79 $20.4 Million - $23.6 Million
564,416 Added 151.26%
937,557 $34.4 Million
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $2.99 Million - $3.89 Million
75,868 Added 25.52%
373,141 $15.2 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $2.38 Million - $3.11 Million
57,122 Added 23.79%
297,273 $15.2 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $1.01 Million - $1.23 Million
23,058 Added 10.62%
240,151 $10.5 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $1.85 Million - $2.2 Million
39,860 Added 22.49%
217,093 $11.4 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $2.52 Million - $3.13 Million
55,184 Added 45.21%
177,233 $9.18 Million
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $2.38 Million - $3.53 Million
57,665 Added 89.56%
122,049 $7.21 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $547,616 - $703,459
-13,952 Reduced 17.81%
64,384 $2.77 Million
Q2 2021

Aug 10, 2021

SELL
$35.91 - $40.68 $1.95 Million - $2.2 Million
-54,174 Reduced 40.88%
78,336 $3.07 Million
Q1 2021

May 17, 2021

BUY
$33.49 - $37.77 $793,545 - $894,960
23,695 Added 21.78%
132,510 $4.8 Million
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $320,207 - $407,171
9,567 Added 9.64%
108,815 $4.01 Million
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $1.02 Million - $1.19 Million
32,074 Added 47.75%
99,248 $3.64 Million
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $696,223 - $844,622
23,115 Added 52.46%
67,174 $2.2 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $459,861 - $657,042
-17,013 Reduced 27.86%
44,059 $1.44 Million
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $4.81 Million - $5.45 Million
-145,963 Reduced 70.5%
61,072 $2.39 Million
Q3 2019

Nov 08, 2019

BUY
$32.49 - $42.13 $1.27 Million - $1.65 Million
39,157 Added 23.32%
207,035 $7.44 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $37,238 - $41,810
1,007 Added 0.6%
167,878 $7.27 Million
Q1 2019

May 14, 2019

BUY
$37.5 - $41.2 $1.33 Million - $1.46 Million
35,367 Added 26.89%
166,871 $7.09 Million
Q4 2018

Feb 13, 2019

BUY
$38.47 - $43.86 $230,820 - $263,160
6,000 Added 4.78%
131,504 $5.74 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $140,568 - $170,501
4,078 Added 3.36%
125,504 $5.53 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $192,570 - $205,299
5,839 Added 5.05%
121,426 $4.41 Million
Q1 2018

May 14, 2018

BUY
$31.91 - $37.02 $640,433 - $742,991
20,070 Added 21.01%
115,587 $4.1 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $401 Million - $426 Million
-12,071,550 Reduced 99.21%
95,517 $3.46 Million
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $108 Million - $119 Million
3,485,273 Added 40.14%
12,167,067 $434 Million
Q2 2017

Aug 14, 2017

BUY
N/A
8,681,794
8,681,794 $292 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.